enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO)
CUSIP: 29415J106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 20,505,656
- Total 13F shares
- 3,289,256
- Share change
- -310,935
- Total reported value
- $17,267,988
- Put/Call ratio
- 6.2%
- Price per share
- $5.25
- Number of holders
- 25
- Value change
- -$1,696,568
- Number of buys
- 11
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 29415J106?
CUSIP 29415J106 identifies NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29415J106:
Top shareholders of NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
3.2%
|
653,870
|
$3,557,053 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3%
|
623,315
|
$3,390,834 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
573,955
|
$3,122,316 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.4%
|
495,736
|
$2,696,804 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1.1%
|
226,308
|
$1,231,116 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.98%
|
201,728
|
$1,097,400 | — | 31 Mar 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.84%
|
172,235
|
$936,958 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
137,456
|
$747,882 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.48%
|
97,550
|
$530,672 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.22%
|
45,561
|
$247,852 | — | 31 Mar 2024 | |
| RIA Advisory Group LLC |
13F
|
Company |
0.21%
|
43,666
|
$237,543 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.2%
|
40,120
|
$218,253 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
37,491
|
$203,951 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
35,142
|
$191,173 | — | 31 Mar 2024 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.17%
|
34,140
|
$186,000 | — | 31 Mar 2024 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
0.16%
|
33,000
|
$179,520 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.12%
|
25,313
|
$137,703 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
24,600
|
$133,824 | — | 31 Mar 2024 | |
| Fermata Advisors, LLC |
13F
|
Company |
0.11%
|
23,198
|
$126,197 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.11%
|
22,402
|
$121,867 | — | 31 Mar 2024 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.09%
|
18,872
|
$103,230 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
16,411
|
$89,276 | — | 31 Mar 2024 | |
| Tamar Securities, LLC |
13F
|
Company |
0.07%
|
13,990
|
$76,106 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
13,873
|
$75,000 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.06%
|
11,350
|
$61,744 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
6,825
|
$37,000 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
5,558
|
$30,235 | — | 31 Mar 2024 | |
| Westside Investment Management, Inc. |
13F
|
Company |
0.02%
|
3,750
|
$20,400 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
3,487
|
$18,970 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
2,095
|
$11,397 | — | 31 Mar 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
860
|
$4,532 | — | 31 Mar 2024 | |
| Craig Glynn |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
75,000
|
— | — | 05 Dec 2023 |
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.